Position in LNTH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,215,915
+$1,276,513 QoQ
Shares Held
19,974
+61.3% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#150
of 462 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026New Age Alpha Advisors, LLC holds $14,948,777 across 10 Drug Manufacturers - Specialty & Generic names. LNTH ranks #3 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
22,262 | $3,752,037 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,267 | $3,395,648 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
This page
|
19,974 | $2,215,915 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
52,689 | $1,826,727 | |
| 5 | ZTS |
Zoetis Inc.
|
22,671 | $1,629,138 | |
| 6 | PRGO |
PERRIGO Co plc
|
106,665 | $1,108,249 | |
| 7 | ALKS |
Alkermes plc.
|
7,508 | $393,419 | |
| 8 | VTRS |
Viatris Inc
|
21,038 | $334,083 |
All Filings in LNTH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,215,915 | 19,974 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $939,402 | 12,385 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $843,188 | 12,670 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $768,683 | 14,987 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,257,942 | 15,367 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,376,648 | 14,105 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,365,070 | 15,259 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||